Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Multiple Myeloma 116Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Recurrence 17Burkitt Lymphoma 14Lymphoma, Large B-Cell, Diffuse 8Neoplasms 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms, Plasma Cell 6Lymphoma 6Leukemia, Biphenotypic, Acute 5Immunoglobulin Light-chain Amyloidosis 5Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Lymphoma, Non-Hodgkin 4Lymphoma, B-Cell 4Waldenstrom Macroglobulinemia 3Neoplasm Metastasis 3Nausea 3Lung Neoplasms 3Leukemia 3Smoldering Multiple Myeloma 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Paraproteinemias 2Ovarian Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Down Syndrome 2

Interventions

Dexamethasone 3naldemedine 1Palonosetron 1Olanzapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Nausea × Dexamethasone × 90 days × Clear all
NCT07537660 2026-04-17

ADGP

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
25 enrolled

Nausea

NCT07537673 2026-04-17

ADTD

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
25 enrolled

Nausea

NCT07537699 2026-04-17

ADDC

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
25 enrolled

Nausea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡